So, TGR5 activation likely promotes intestinal healing via a dual mechanism encompassing an anti-inflammatory activity and a pro-regenerative program in epithelial cells and could be further explored in CRC clinical settings. The gene discussed is GPBAR1; the disease is colorectal carcinoma.